Lidocaine/Oxybutynin(Trigone Pharma)

N/A

Report date: 2023/05/22 10:19:23

NME

Base Information

Drug NameLidocaine/Oxybutynin(Trigone Pharma)

Drug Alias NameTRG-100

ClassificationSmall molecules

Mechanisms of ActionMuscarinic acetylcholine receptor M1 antagonistsMuscarinic acetylcholine receptor M2 antagonistsMuscarinic acetylcholine receptor M3 antagonists +[4]

TargetsMuscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M2Muscarinic acetylcholine receptor M3

Therapy Area/IndicationsCystitis, Interstitial

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTrigone Pharma Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsCystitis, Interstitial

Inactive IndicationsN/A

Other Information

ATC CodeN/A